Literature DB >> 17883278

Cell-specific delivery of polymeric nanoparticles to carbohydrate-tagging cells.

Yasuhiko Iwasaki1, Haruki Maie, Kazunari Akiyoshi.   

Abstract

Carbohydrates on cell surfaces contribute a variety of communications between the cell and its environment, and they have been assumed to act as markers for cellular recognition. In this research, 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer nanoparticles, which can react with specific carbohydrates of target cells, were newly prepared to serve as novel drug carriers. A water-soluble MPC polymer bearing hydrazide groups (PMBH) was synthesized by conventional radical polymerization. The MPC polymer showed amphiphilic nature and worked as an emulsifier to form nanoparticles. The nanoparticles covered with PMBH were prepared by the solvent evaporation method and exhibited monodispersity. They were approximately 200 nm in diameter and -2.0 mV in surface potential. According to a surface analysis of the nanoparticles, phosphorylcholine and hydrazide groups were observed, and the surface was fully covered with PMBH. Unnatural carbohydrates having ketone groups on human cervical carcinoma cell (HeLa) surfaces were expressed by treatment with levulinoyl mannosamine (ManLev). When the PMBH nanoparticles were in contact with the ManLev-treated HeLa cells, they accumulated in the cells. In contrast, the nanoparticles were not observed in native HeLa cells (without unnatural carbohydrates). These results indicate that the hydrazide groups of the nanoparticles selectively reacted to the ketone groups of the carbohydrates on the cell surface. The PMBH nanoparticles immobilized with anticancer drugs such as doxorubicin or paclitaxel were in contact with either ManLev-treated or untreated HeLa cells. The viability of the ManLev-treated HeLa cells was effectively reduced, but that of the untreated cells was preserved. This indicated that the anticancer drugs were selectively delivered to the ManLev-treated cells. Nonspecific cellular uptake of the nanoparticles was effectively reduced by MPC polymer coating. Furthermore, the immobilization processes of the drugs differed because of the solubility of the drugs. In conclusion, cellular-specific drug delivery by means of the novel nanoparticles was demonstrated with the selective reaction between unnatural carbohydrates on the cell surface and the hydrazide groups bearing the phosphorylcholine polymer nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883278     DOI: 10.1021/bm700606z

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  10 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

2.  19F- and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic delivery.

Authors:  Wenjun Du; Zhiqiang Xu; Andreas M Nyström; Ke Zhang; Jeffrey R Leonard; Karen L Wooley
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 3.  Carbohydrate engineered cells for regenerative medicine.

Authors:  Jian Du; Kevin J Yarema
Journal:  Adv Drug Deliv Rev       Date:  2010-02-01       Impact factor: 15.470

Review 4.  Metabolic glycoengineering: sialic acid and beyond.

Authors:  Jian Du; M Adam Meledeo; Zhiyun Wang; Hargun S Khanna; Venkata D P Paruchuri; Kevin J Yarema
Journal:  Glycobiology       Date:  2009-08-12       Impact factor: 4.313

5.  Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates.

Authors:  Cristina Y Zamora; Marc d'Alarcao; Krishna Kumar
Journal:  Bioorg Med Chem Lett       Date:  2013-04-10       Impact factor: 2.823

6.  Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.

Authors:  Lili Wang; Min Li; Na Zhang
Journal:  Int J Nanomedicine       Date:  2012-06-29

7.  100th Anniversary of Macromolecular Science Viewpoint: Re-Engineering Cellular Interfaces with Synthetic Macromolecules Using Metabolic Glycan Labeling.

Authors:  Ruben M F Tomás; Matthew I Gibson
Journal:  ACS Macro Lett       Date:  2020-06-25       Impact factor: 6.903

Review 8.  Nanoparticle delivery systems for substance use disorder.

Authors:  Vishal Kasina; Robert J Mownn; Raman Bahal; Gregory C Sartor
Journal:  Neuropsychopharmacology       Date:  2022-03-28       Impact factor: 8.294

Review 9.  Modeling Polyzwitterion-Based Drug Delivery Platforms: A Perspective of the Current State-of-the-Art and Beyond.

Authors:  Sousa Javan Nikkhah; Matthias Vandichel
Journal:  ACS Eng Au       Date:  2022-05-03

Review 10.  Glycotherapy: new advances inspire a reemergence of glycans in medicine.

Authors:  Jason E Hudak; Carolyn R Bertozzi
Journal:  Chem Biol       Date:  2013-11-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.